Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus. (Q35185711)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Chin Hur

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

17

Paul J Limburg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

15

Thomas C Smyrk

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

3

Nathan R Foster

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

13

Ellen Richmond

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

Cancer Prevention Network

16 February 2020

18

object named as

Cancer Prevention Network

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1

Amitabh Chak

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

2

Navtej S Buttar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

5

Norman E Marcon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

7

Marcia R Cruz-Correa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Drew K Seisler

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Robert Schoen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Prateek Sharma

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

David A Katzka

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Luz M Rodriguez

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Anamay N Sharma

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Sumithra J Mandrekar

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

language of work or name

English

0 references

publication date

15 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

Clinical Gastroenterology and Hepatology

16 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

665-72.e1-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control study

16 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Association of Barrett's esophagus with type II Diabetes Mellitus: results from a large population-based case-control study

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

13 July 2018

Cancer statistics, 2013

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Serum adiponectin, resistin, leptin concentration and central adiposity parameters in Barrett's esophagus patients with and without intestinal metaplasia in comparison to healthy controls and patients with GERD.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Molecular mechanisms of cancer development in obesity

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Association of insulin and insulin-like growth factors with Barrett's oesophagus.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

American Gastroenterological Association medical position statement on the management of Barrett's esophagus

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Serum leptin and adiponectin levels and risk of Barrett's esophagus and intestinal metaplasia of the gastroesophageal junction

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Association of adiponectin multimers with Barrett's oesophagus

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

13 July 2018

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Antidiabetic therapies affect risk of pancreatic cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Does type 2 diabetes influence the risk of oesophageal adenocarcinoma?

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Insulin and insulin-like growth factor signalling in neoplasia

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Metformin and reduced risk of cancer in diabetic patients

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Insulin-like growth factor physiology and neoplasia

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Metformin as an addition to conventional chemotherapy in breast cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Barrett esophagus: prevalence of central adiposity, metabolic syndrome, and a proinflammatory state.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

Leptin and the risk of Barrett's oesophagus.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

The Development and Validation of an Endoscopic Grading System for Barrett’s Esophagus: The Prague C & M Criteria

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4362887

15 November 2018

1 reference

12 December 2020

Obesity and mortality

1 reference

PubMed

12 December 2020

1 reference

12 December 2020

A Pilot Study of the Association of Low Plasma Adiponectin and Barrett's Esophagus

1 reference

PubMed

12 December 2020

Adiponectin and Barrett's esophagus

1 reference

PubMed

12 December 2020

10.1016/J.CGH.2014.08.040

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25218668%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

PubMed publication ID

25218668

1 reference